SPRINT to lower blood pressure targets

Epidemiologic studies have demonstrated increasing cardiovascular risk at a systolic blood pressure above 115 mmHg.¬† However, blood pressure treatment targets are less clear with clinical trials limited to evidence of benefit below 150mmHg. The Systolic Blood Pressure Intervention Trial (SPRINT) sought to determine outcomes following treatment to a target of less than 120mmHg (intensive treatment) […]

Read More…